These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19106164

  • 1. Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE, Geborek P, Saxne T.
    Rheumatology (Oxford); 2009 Mar; 48(3):243-5. PubMed ID: 19106164
    [Abstract] [Full Text] [Related]

  • 2. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
    van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, Wolbink GJ, van den Hoogen FH.
    Ann Rheum Dis; 2008 Dec; 67(12):1697-701. PubMed ID: 18245109
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE, Gülfe A, Saxne T, Geborek P.
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM, Cohen SB, Moreland LW, Schiff M, Mease PJ, Smith DB, Keenan G, Kremer JM, iRAMT Study Group.
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rødevand E, Kaufmann C, Mikkelsen K, Kvien TK.
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [Abstract] [Full Text] [Related]

  • 6. Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.
    Kristensen LE, Saxne T, Nilsson JA, Geborek P.
    Arthritis Res Ther; 2006 Apr; 8(6):R174. PubMed ID: 17121678
    [Abstract] [Full Text] [Related]

  • 7. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 8. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 9. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
    Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.
    Rheumatology (Oxford); 2008 Jun; 47(6):872-6. PubMed ID: 18400836
    [Abstract] [Full Text] [Related]

  • 10. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
    Kapetanovic MC, Larsson L, Truedsson L, Sturfelt G, Saxne T, Geborek P.
    Arthritis Res Ther; 2006 Jun; 8(4):R131. PubMed ID: 16869978
    [Abstract] [Full Text] [Related]

  • 11. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
    Flendrie M, Creemers MC, van Riel PL.
    Rheumatology (Oxford); 2007 Jan; 46(1):146-9. PubMed ID: 16782732
    [Abstract] [Full Text] [Related]

  • 12. Infliximab dose and clinical status: results of 2 studies in 1642 patients with rheumatoid arthritis.
    Stern R, Wolfe F.
    J Rheumatol; 2004 Aug; 31(8):1538-45. PubMed ID: 15290732
    [Abstract] [Full Text] [Related]

  • 13. A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.
    Durez P, Van den Bosch F, Corluy L, Veys EM, De Clerck L, Peretz A, Malaise M, Devogelaer JP, Vastesaeger N, Geldhof A, Westhovens R.
    Rheumatology (Oxford); 2005 Apr; 44(4):465-8. PubMed ID: 15695306
    [Abstract] [Full Text] [Related]

  • 14. The use of infliximab in academic rheumatology practice: an audit of early clinical experience.
    Fitzcharles MA, Clayton D, Ménard HA.
    J Rheumatol; 2002 Dec; 29(12):2525-30. PubMed ID: 12465146
    [Abstract] [Full Text] [Related]

  • 15. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
    Buch MH, Bingham SJ, Bryer D, Emery P.
    Rheumatology (Oxford); 2007 Jul; 46(7):1153-6. PubMed ID: 17478470
    [Abstract] [Full Text] [Related]

  • 16. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [Abstract] [Full Text] [Related]

  • 17. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
    Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.
    Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
    [Abstract] [Full Text] [Related]

  • 18. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P.
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [Abstract] [Full Text] [Related]

  • 19. Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.
    Haraoui B, Cameron L, Ouellet M, White B.
    J Rheumatol; 2006 Jan; 33(1):31-6. PubMed ID: 16395747
    [Abstract] [Full Text] [Related]

  • 20. Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center.
    Agarwal SK, Maier AL, Chibnik LB, Coblyn JS, Fossel A, Lee R, Fanikos J, Fiumara K, Lowry C, Weinblatt ME.
    Arthritis Rheum; 2005 Dec 15; 53(6):872-8. PubMed ID: 16342095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.